Literature DB >> 21858437

New directions in clinical outcomes assessment : VIth International Symposium on Interventional Electrophysiology in the Management of Cardiac Arrhythmias.

Sana M Al-Khatib1.   

Abstract

In recent years, electrophysiology clinical research has made tremendous progress. Not only have the standards for conducting research and assessing clinical outcomes improved substantially, but the power of well-conducted and designed randomized clinical trials has been realized. This has led to the emergence of a plethora of randomized clinical trials in electrophysiology. Despite these improvements, there is an immense need to explore and develop better approaches for assessing clinical outcomes. In this article, I review the strengths, challenges, and limitations of randomized clinical trials, especially as they relate to the field of electrophysiology. To address some of these challenges, I propose potential solutions that involve enhancing clinical trials and complementing them with large registries and databases of electronic medical records. If prudently developed and executed, these new directions in assessing clinical outcomes have great potential to inform, and thereby improve the care of patients receiving electrophysiologic interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21858437     DOI: 10.1007/s10840-011-9608-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  18 in total

1.  Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.

Authors:  Bryan R Luce; Judith M Kramer; Steven N Goodman; Jason T Connor; Sean Tunis; Danielle Whicher; J Sanford Schwartz
Journal:  Ann Intern Med       Date:  2009-06-30       Impact factor: 25.391

Review 2.  The impact of health information technology on the quality of medical and health care: a systematic review.

Authors:  Aziz Jamal; Kirsten McKenzie; Michele Clark
Journal:  Health Inf Manag       Date:  2009       Impact factor: 3.185

3.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification.

Authors:  David M Kent; Rodney A Hayward
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

4.  Prime time for Bayes.

Authors:  J B Kadane
Journal:  Control Clin Trials       Date:  1995-10

Review 5.  Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank.

Authors:  Sana M Al-Khatib; Hugh Calkins; Benjamin C Eloff; Peter Kowey; Stephen C Hammill; Kenneth A Ellenbogen; Danica Marinac-Dabic; Albert L Waldo; Ralph G Brindis; David J Wilbur; Warren M Jackman; Marcia S Yaross; Andrea M Russo; Eric Prystowsky; Paul D Varosy; Thomas Gross; Ellen Pinnow; Mintu P Turakhia; Mitchell W Krucoff
Journal:  Am Heart J       Date:  2010-10       Impact factor: 4.749

Review 6.  Barriers to the acceptance of electronic medical records by physicians from systematic review to taxonomy and interventions.

Authors:  Albert Boonstra; Manda Broekhuis
Journal:  BMC Health Serv Res       Date:  2010-08-06       Impact factor: 2.655

7.  Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Authors:  Jeptha P Curtis; Jeffrey J Luebbert; Yongfei Wang; Saif S Rathore; Jersey Chen; Paul A Heidenreich; Stephen C Hammill; Rachel I Lampert; Harlan M Krumholz
Journal:  JAMA       Date:  2009-04-22       Impact factor: 56.272

8.  Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation.

Authors:  Atul Aggarwal; Yongfei Wang; John S Rumsfeld; Jeptha P Curtis; Paul A Heidenreich
Journal:  Heart Rhythm       Date:  2009-08-05       Impact factor: 6.343

9.  Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.

Authors:  Pamela N Peterson; Stacie L Daugherty; Yongfei Wang; Humberto J Vidaillet; Paul A Heidenreich; Jeptha P Curtis; Frederick A Masoudi
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.